|1.||Kiefer, Falk: 8 articles (04/2009 - 01/2003)|
|2.||Lehert, Philippe: 7 articles (03/2012 - 11/2004)|
|3.||Mason, Barbara J: 6 articles (02/2015 - 08/2006)|
|4.||Erickson, Craig A: 5 articles (12/2014 - 11/2010)|
|5.||McDougle, Christopher J: 5 articles (12/2014 - 11/2010)|
|6.||Heilig, Markus: 5 articles (03/2014 - 01/2002)|
|7.||Wiedemann, Klaus: 5 articles (08/2006 - 01/2003)|
|8.||Wink, Logan K: 4 articles (12/2014 - 12/2011)|
|9.||Savage, Julian: 4 articles (01/2014 - 01/2007)|
|10.||Jahn, Holger: 4 articles (08/2006 - 01/2003)|
|1.||Alcoholism (Alcohol Abuse)
09/01/2012 - "GlyT-1 inhibition may represent a new treatment principle for alcoholism that is superior to acamprosate."
10/09/2003 - "Acamprosate has been shown to be effective and safe in relapse prevention of alcoholism. "
01/01/2002 - "Exposure-induced but not spontaneous alcohol intake is antagonized by acamprosate, a compound clinically effective in human alcoholism. "
02/01/1998 - "Acamprosate (calcium-acetyl homotaurinate) is a relatively new compound developed for the treatment of alcoholism and has been shown to be effective in attenuating relapse in human alcoholics. "
05/01/2000 - "The properties of acamprosate (calcium acetylhomotaurate), a new remedy for the treatment of alcoholism, are reviewed. "
01/01/2012 - "(1)To study the effectiveness of acamprosate in providing subjective relief and objective improvement in patients having tinnitus of sensorineural origin. "
08/16/2014 - "Acamprosate may decrease the severity of tinnitus, but the level of evidence is low. "
01/01/2012 - "Acamprosate is an effective drug in treating the severity of sensorineural tinnitus without causing much of the side effects."
01/01/2012 - "The effect of acamprosate and placebo on subjective relief and objective improvement was evaluated by using modified tinnitus severity, QOL scores and audiometry with tinnitus matching in frequency and loudness. "
01/01/2012 - "Role of acamprosate in sensorineural tinnitus."
09/01/2000 - "In contrast, acamprosate improved neurological outcome, with stroke-related death occurring in one animal only and a minor neurological deficit in the surviving rats. "
12/01/2015 - "Taken into account its excellent tolerability, its sustained effects on neurologic recovery, brain tissue survival, and neural remodeling, acamprosate is an intriguing candidate for adjuvant future stroke treatment. "
12/01/2015 - "Acamprosate yielded sustained neuroprotection and increased neurologic recovery when given no later than 12 hours after stroke. "
01/01/2016 - "The American Occupational Therapy Association (AOTA) Evidence-Based Practice Project has developed a table summarizing the research opportunities on adults with stroke. "
09/01/2015 - "Findings from the systematic reviews on this topic were published in the January/February 2015 issue of the American Journal of Occupational Therapy and in AOTA's Occupational Therapy Practice Guidelines for Adults With Stroke (Wolf & Nilsen, 2015). "
|7.||gamma-Aminobutyric Acid (GABA)
|8.||beta-Endorphin (Endorphin, beta)
|9.||Brain-Derived Neurotrophic Factor (BDNF)
|1.||Drug Therapy (Chemotherapy)
|2.||Occupational Therapy (Therapy, Occupational)
|4.||Hearing Aids (Hearing Aid)